Physician

Adem Aktas, D.O.

According to 2025 Medicare claims, Adem Aktas, D.O. (NPI: 1811429715) practices physical medicine and rehabilitation in the Rochester, NY market, with the plurality of this provider's patient population coming from Monroe, NY. This provider's primary affiliated billing organization is UNIVERSITY OF ROCHESTER PHYSICAL MEDICINE AND REHABILITATION (NPI: 1649434648; TIN: 160743209) and primary practice location at 14623-5851.

Aktas' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 151 traditional Medicare patients, billed 421 HCPCS/CPT codes, and received $40,257 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 322 prescription claims across 156 beneficiaries totaling $4,085 in drug costs, led by Gabapentin (Gabapentin). Open Payments data shows 2 records totaling $212. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $3,486 and ending at $4,085. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$20K$40K2022 Medicare payment: $15,316 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $34,698 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $40,257 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
202281171$15,316
2023165421$34,698
2024151421$40,257

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$11K$22K2018 Drug cost: $3,486 (USD; Tot_Drug_Cst)2019 Drug cost: $10,652 (USD; Tot_Drug_Cst)2020 Drug cost: $6,904 (USD; Tot_Drug_Cst)2021 Drug cost: $16,920 (USD; Tot_Drug_Cst)2022 Drug cost: $21,638 (USD; Tot_Drug_Cst)2023 Drug cost: $5,747 (USD; Tot_Drug_Cst)2024 Drug cost: $4,085 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181483$3,486
201983241$10,652
202074193$6,904
2021213458$16,920
2022273723$21,638
2023146360$5,747
2024156322$4,085

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more7979$114
64483Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level2737$102
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more84111$94
64493Injection of lower or sacral spine facet joint using imaging guidance, single level1119$90
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more3741$56

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
GabapentinGabapentin1324,488$1,426
PregabalinPregabalin421,245$564
CelecoxibCelecoxib14420$541
Duloxetine HclDuloxetine Hcl16644$349
MethylprednisoloneMethylprednisolone18108$140

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.2$212Abbott Laboratories
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Adem Aktas, D.O.?

Tedicare shows public-source Medicare data for Adem Aktas, D.O. (NPI 1811429715), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adem Aktas, D.O. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adem Aktas, D.O.?

Adem Aktas, D.O. is linked to UNIVERSITY OF ROCHESTER PHYSICAL MEDICINE AND REHABILITATION (billing NPI 1649434648) in the available physician profile data.

Does Adem Aktas, D.O. have Open Payments data?

Adem Aktas, D.O. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.